NewsAAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food AllergyHealthDay.comMarch 6, 2026
NewsAAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for OsteoporosisHealthDay.comMarch 6, 2026
Subset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based ChemoimmunotherapyMarch 6, 2026
NewsAppropriate Use Criteria Released for Peripheral Artery InterventionHealthDay.comDecember 18, 2018
